|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Tumor Biology |
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health (M.A.P., E.H.O., M.J.M.), Bethesda, MD 20892, USA; Department of Neurosurgery (M.A.P., C.M., M.K., A.B.) and Institute of Pathology (T.S.), University of Regensburg, Regensburg, Germany; Department of Microbiology and Molecular Genetics, College of Medicine, University of California at Irvine (S.-Y.L., E.J.S.), Irvine, CA 92697, USA; Basic Research Program, SAIC-Frederick, Inc., Laboratory of Immunobiology, National Cancer Institute at Frederick (S.I.), Frederick, MD 21702, USA
1 Send correspondence to Marsha Merrill, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bldg. 10, Rm. 5D37, 10 Center Drive, Bethesda, MD 20892-1414, USA (merrillm{at}ninds.nih.gov).
Abstract
Malignant brain tumors exhibit distinct metabolic characteristics. Despite high levels of lactate, the intracellular pH of brain tumors is more alkaline than normal brain. Additionally, with increasing malignancy, brain tumors display intratumoral hypoxia. Carbonic anhydrase (CA) IX and XII are transmembrane isoenzymes that are induced by tissue hypoxia. They participate in regulation of pH homeostasis by catalyzing the reversible hydration of carbon dioxide. The aim of our study was to investigate whether brain tumors of different histology and grade of malignancy express elevated levels of CA IX and XII as compared to normal brain. We analyzed 120 tissue specimens from brain tumors (primary and metastatic) and normal brain for CA IX and XII expression by immunohistochemistry, Western blot, and in situ hybridization. Whereas normal brain tissue showed minimal levels of CA IX and XII expression, expression in tumors was found to be upregulated with increased level of malignancy. Hemangioblastomas, from patients with von Hippel-Lindau disease, also displayed high levels of CA IX and XII expression. Comparison of CA IX and XII staining with HIF-1
staining revealed a similar microanatomical distribution, indicating hypoxia as a major, but not the only, induction factor. The extent of CA IX and XII staining correlated with cell proliferation, as indicated by Ki67 labeling. The results demonstrate that CA IX and XII are upregulated in intrinsic and metastatic brain tumors as compared to normal brain tissue. This may contribute to the management of tumor-specific acid load and provide a therapeutic target.
References
An, W.G., Kanekal, M., Simon, M.C., Maltepe, E., Blagosklonny, M.V., and Neckers, L.M. (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392, 405-408.[CrossRef][Medline]
Arnold, J.B., Junck, L., and Rottenberg, D.A. (1985) In vivo measurement of regional brain and tumor pH using [14C]dimethyloxazolidinedi one and quantitative autoradiography. J. Cereb. Blood Flow Metab. 5, 369-375.[Medline]
Barnea, G., Grumet, M., Sap, J., Margolis, R.U., and Schlessinger, J. (1994) Close similarity between receptor-linked tyrosine phosphatase and rat brain proteoglycan. Cell 76, 205.[CrossRef][Medline]
Breton, S. (2001) The cellular physiology of carbonic anhydrases. J. Pancreas 2, 159-164 (suppl.).
Burger, P.C., Vogel, F.S., Green, S.B., and Strike, T.A. (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prog nostic implications. Cancer 56, 1106-1111.[CrossRef][ISI][Medline]
Cadoux-Hudson, T.A., Blackledge, M.J., Rajagopalan, B., Taylor, D.J., and Radda, G.K. (1989) Human primary brain tumour metabolism in vivo: A phosphorus magnetic resonance spectroscopy study. Br. J. Cancer 60, 430-436.[Medline]
Chegwidden, W.R., and Carter, N.D. (2000) Introduction to the carbonic anhydrases. EXS 90, 14-28.
Collingridge, D.R., Piepmeier, J.M., Rockwell, S., and Knisely, J.P. (1999) Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother. Oncol. 53, 127-131.[CrossRef][ISI][Medline]
Davis, F.G., McCarthy, B., and Jukich, P. (1999) The descriptive epidemiol ogy of brain tumors. Neuroimaging Clin. N. Am. 9, 581-594.[ISI][Medline]
Di Chiro, G., DeLaPaz, R.L., Brooks, R.A., Sokoloff, L., Kornblith, P.L., Smith, B.H., Patronas, N.J., Kufta, C.V., Kessler, R.M., Johnston, G.S., Manning, R.G., and Wolf, A.P. (1982) Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32, 1323-1329.
Giatromanolaki, A., Koukourakis, M.I., Sivridis, E., Pastorek, J., Wykoff, C.C., Gatter, K.C., and Harris, A.L. (2001) Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res. 61, 7992-7998.
Herholz, K., Heindel, W., Luyten, P.R., denHollander, J.A., Pietrzyk, U., Voges, J., Kugel, H., Friedmann, G., and Heiss, W.-D. (1992) In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann. Neurol. 31, 319-327.[CrossRef][Medline]
Hockel, M., and Vaupel, P. (2001) Biological consequences of tumor hypoxia. Semin. Oncol. 28, 36-41 (suppl.).
Imaya, H. (1994) Lactate metabolism conducted by rat C6-glioma in the cells culture. J. Neurosurg. Sci. 38, 223-227.[Medline]
Ivanov, S.V., Kuzmin, I., Wei, M.H., Pack, S., Geil, L., Johnson, B.E., Stanbridge, E.J., and Lerman, M.I. (1998) Down-regulation of transmem brane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc. Natl. Acad. Sci. USA 95, 12596-12601.
Ivanov, S., Liao, S.Y., Ivanova, A., Danilkovitch-Miagkova, A., Tarasova, N., Weirich, G., Merrill, M.J., Proescholdt, M.A., Oldfield, E.H., Lee, J., Zavada, J., Waheed, A., Sly, W., Lerman, M.I., and Stanbridge, E.J. (2001) Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am. J. Pathol. 158, 905-919.
Jahde, E., Rajewsky, M.F., and Baumgartl, H. (1982) pH distributions in transplanted neural tumors and normal tissues of BDIX rats as mea sured with pH microelectrodes. Cancer Res. 42, 1498-1504.
Kaluz, S., Kaluzova, M., Chrastina, A., Olive, P.L., Pastorekova, S., Pastorek, J., Lerman, M.I., and Stanbridge, E.J. (2002) Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: A role for phosphatidylinositol 3'-kinase. Cancer Res. 62, 4469-4477.
Kaluzova, M., Pastorekova, S., Pastorek, J., and Kaluz, S. (2000) P53 tumour suppressor modulates transcription of the TATA-less gene cod ing for the tumour-associated carbonic anhydrase MN/CA IX in MaTu cells. Biochim. Biophys. Acta 1491, 20-26.[Medline]
Kanno, H., Shuin, T., Kondo, K., Yamamoto, I., Ito, S., Shinonaga, M., Yoshida, M., and Yao, M. (1997) Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors. Cancer Res. 57, 1035-1038.
Koukourakis, M.I., Giatromanolaki, A., Sivridis, E., Simopoulos, K., Pastorek, J., Wykoff, C.C., Gatter, K.C., and Harris, A.L. (2001) Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin. Cancer Res. 7, 3399-3403.
Liao, S.Y., and Stanbridge, E.J. (2000) Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undeter mined significance is a diagnostic biomarker of cervical dysplasia and neoplasia. Cancer 88, 1108-1121.[CrossRef][Medline]
Liao, S.Y., Brewer, C., Zavada, J., Pastorek, J., Pastorekova, S., Manetta, A., Berman, M.L., DiSaia, P.J., and Stanbridge, E.J. (1994) Identification of the MN antigen as a diagnostic biomarker of cervical intraepithe lial squamous and glandular neoplasia and cervical carcinomas. Am. J. Pathol. 145, 598-609.[Abstract]
Liao, S.Y., Aurelio, O.N., Jan, K., Zavada, J., and Stanbridge, E.J. (1997) Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res. 57, 2827-2831.
Loncaster, J.A., Harris, A.L., Davidson, S.E., Logue, J.P., Hunter, R.D., Wycoff, C.C., Pastorek, J., Ratcliffe, P.J., Stratford, I.J., and West, C.M. (2001) Carbonic anhydrase (CA IX) expression, a potential new intrin sic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61, 6394-6399.
Maher, E.A., Furnari, F.B., Bachoo, R.M., Rowitch, D.H., Louis, D.N., Cavenee, W.K., and DePinho, R.A. (2001) Malignant glioma: Genetics and biology of a grave matter. Genes Dev. 15, 1311-1333.
Mangiardi, J.R., and Yodice, P. (1990) Metabolism of malignant astrocy toma. Neurosurgery 26, 1-19.[Medline]
Martinez-Zaguilan, R., Seftor, E.A., Seftor, R.E., Chu, Y.W., Gillies, R.J., and Hendrix, M.J. (1996) Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis 14, 176-186.[CrossRef][ISI][Medline]
Olive, P.L., Aquino-Parsons, C., MacPhail, S.H., Liao, S.Y., Raleigh, J.A., Lerman, M.I., and Stanbridge, E.J. (2001) Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res. 61, 8924-8929.
Opavsky, R., Pastorekova, S., Zelnik, V., Gibadulinova, A., Stanbridge, E.J., Zavada, J., Kettmann, R., and Pastorek, J. (1996) Human MN/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships. Genomics 33, 480-487.[CrossRef][ISI][Medline]
Papavassiliou, E., Gogate, N., Proescholdt, M., Heiss, J.D., Walbridge, S., Edwards, N.A., Oldfield, E.H., and Merrill, M.J. (1997) Vascular endo thelial growth factor (vascular permeability factor) expression in injured rat brain. J. Neurosci. Res. 49, 451-460.[CrossRef][ISI][Medline]
Parkkila, S., Rajaniemi, H., Parkkila, A.K., Kivela, J., Waheed, A., Pastorekova, S., Pastorek, J., and Sly, W.S. (2000) Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc. Natl. Acad. Sci. USA 97, 2220-2224.
Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J.P., Zelnik, V., Opavsky, R., Zat'ovicova, M., Liao, S., Portetelle, D., Stanbridge, E.J., Zavada, J., Burny, A., and Kettmann, R. (1994) Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9, 2877-2888.[ISI][Medline]
Peles, E., Nativ, M., Campbell, P.L., Sakurai, T., Martinez, R., Lev, S., Clary, D.O., Schilling, J., Barnea, G., Plowman, G.D., Grumet, M., and Schlessinger, J. (1995) The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell 82, 251-260.[CrossRef][ISI][Medline]
Pugh, C.W., and Ratcliffe, P.J. (2003) The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 13, 83-89.[CrossRef][ISI][Medline]
Rottenberg, D.A., Ginos, J.Z., Kearfott, K.J., Junck, L., and Bigner, D.D. (1984) In vivo measurement of regional brain tissue pH using positron emission tomography. Ann. Neurol. 15, S98-S102 (suppl.).
Rottenberg, D.A., Ginos, J.Z., Kearfott, K.J., Junck, L., Dhawan, V., and Jarden, J.O. (1985) In vivo measurement of brain tumor pH using [11C]DMO and positron emission tomography. Ann. Neurol. 17, 70-79.[Medline]
Saarnio, J., Parkkila, S., Parkkila, A.K., Haukipuro, K., Pastorekova, S., Pastorek, J., Kairaluoma, M.I., and Karttunen, T.J. (1998a) Immu nohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am. J. Pathol. 153, 279-285.
Saarnio, J., Parkkila, S., Parkkila, A.K., Waheed, A., Casey, M.C., Zhou, X.Y., Pastorekova, S., Pastorek, J., Karttunen, T., Haukipuro, K., Kai raluoma, M.I., and Sly, W.S. (1998b) Immunohistochemistry of car bonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity. J. Histochem. Cytochem. 46, 497-504.
Schmaltz, C., Hardenbergh, P.H., Wells, A., and Fisher, D.E. (1998) Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18, 2845-2854.
Sly, W.S., and Hu, P.Y. (1995) Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 64, 375-401.[CrossRef][ISI][Medline]
Stewart, M., Talks, K., Leek, R., Turley, H., Pezzella, F., Harris, A., and Gat ter, K. (2002) Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology 40, 253-260.[CrossRef][ISI][Medline]
Supuran, C.T., Briganti, F., Tilli, S., Chegwidden, W.R., and Scozzafava, A. (2001) Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents? Bioorg. Med. Chem. 9, 703-714.[CrossRef][Medline]
Tashian, R.E., Hewett-Emmett, D., Carter, N., and Bergenhem, N.C. (2000) Carbonic anhydrase (CA)-related proteins (CA-RPs), and transmem brane proteins with CA or CA-RP domains. EXS 90, 105-120.
Tso, C.L., Zisman, A., Pantuck, A., Calilliw, R., Hernandez, J.M., Paik, S., Nguyen, D., Gitlitz, B., Shintaku, P.I., de Kernion, J., Figlin, R., and Belldegrun, A. (2001) Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimu lating factor. Cancer Res. 61, 7925-7933.
Ulmasov, B., Waheed, A., Shah, G.N., Grubb, J.H., Sly, W.S., Tu, C., and Silverman, D.N. (2000) Purification and kinetic analysis of recombinant CA XII, a membrane carbonic anhydrase overexpressed in certain cancers. Proc. Natl. Acad. Sci. USA 97, 14212-14217.
Valk, P.E., Mathis, C.A., Prados, M.D., Gilbert, J.C., and Budinger, T.F. (1992) Hypoxia in human gliomas: Demonstration by PET with fluorine-18-fluoromisonidazole. J. Nucl. Med. 33, 2133-2137.
Vaupel, P., Kelleher, D.K., and Hockel, M. (2001) Oxygen status of malig nant tumors: Pathogenesis of hypoxia and significance for tumor ther apy. Semin. Oncol. 28, 29-35 (suppl.).[CrossRef]
Vermylen, P., Roufosse, C., Burny, A., Verhest, A., Bosschaerts, T., Pastorekova, S., Ninane, V., and Sculier, J.P. (1999) Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur. Respir. J. 14, 806-811.
Warburg, O. (1931) The metabolism of the carcinoma cell. In: Warburg, O. (Ed.), The metabolism of tumours: Investigations from the Kaiser Wilhelm Institute for Biology, Berlin-Dahlem. New York: Richard R. Smith, pp. 129-169.
Webb, S.D., Sherratt, J.A., and Fish, R.G. (1999) Alterations in proteo lytic activity at low pH and its association with invasion: A theoretical model. Clin. Exp. Metastasis 17, 397-407.[CrossRef][ISI][Medline]
Wilkinson, D.G. (1992) The theory and practice of in situ hybridization. In: Wilkinson, D.G. (Ed.), In Situ Hybridization: A Practical Approach. Oxford: Oxford University Press, 1-13.
Wingo, T., Tu, C., Laipis, P.J., and Silverman, D.N. (2001) The catalytic properties of human carbonic anhydrase IX. Biochem. Biophys. Res. Commun. 288, 666-669.[CrossRef][Medline]
Wykoff, C.C., Beasley, N.J., Watson, P.H., Turner, K.J., Pastorek, J., Sibtain, A., Wilson, G.D., Turley, H., Talks, K.L., Maxwell, P.H., Pugh, C.W., Ratcliffe, P.J., and Harris, A.L. (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60, 7075-7083.
Wykoff, C.C., Beasley, N., Watson, P.H., Campo, L., Chia, S.K., English, R., Pastorek, J., Sly, W.S., Ratcliffe, P., and Harris, A.L. (2001) Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am. J. Pathol. 158, 1011-1019.
Zavada, J., Zavadova, Z., Pastorek, J., Biesova, Z., Jezek, J., and Velek, J. (2000) Human tumour-associated cell adhesion protein MN/CA IX: Identification of M75 epitope and of the region mediating cell adhesion. Br. J. Cancer 82, 1808-1813.[CrossRef][ISI][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
